Antitumor Effects of Recombinant Antivascular Protein ABRaA-VEGF121 Combined with IL-12 Gene Therapy

Author： Ciomber Agnieszka   Smagur Andrzej   Mitrus Iwona   Cichoń Tomasz   Smolarczyk Ryszard   Sochanik Aleksander   Szala Stanisław   Jarosz Magdalena  

Publisher： Springer Publishing Company

ISSN： 0004-069X

Source： Archivum Immunologiae et Therapiae Experimentalis, Vol.62, Iss.2, 2014-04, pp. : 161-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inducing long-term survival with lasting anti-tumor immunity in treating B cell lymphoma by a combined dendritic cell-based and hydrodynamic plasmid-encoding IL-12 gene therapy

By Chen H-W.  

International Immunology, Vol. 15, Iss. 3, 2003-03 ,pp. : 427-435

Oxford University Press

Access to resources Recommend Favorite

IL-12 Gene Therapy of Leukemia with Hematopoietic Progenitor Cells without the Toxicity of Systemic IL-12 Treatment

By Xu Y.X.   Gao X.   Janakiraman N.   Chapman R.A.   Gautam S.C.  

Clinical Immunology, Vol. 98, Iss. 2, 2001-02 ,pp. : 180-189

Academic Press

Access to resources Recommend Favorite

Combination of Recombinant Xenogeneic Endoglin DNA and Protein Vaccination Enhances Anti-tumor Effects

By Tan Guang-Hong   Li Yue-Nan   Huang Feng-Ying   Wang Hua   Bai Rui-Zhen   Jang Jie  

Immunological Investigations, Vol. 36, Iss. 4, 2007-07 ,pp. : 423-440

Informa Healthcare

Access to resources Recommend Favorite

Safety Considerations of Recombinant Protein Therapy: Introductory Comments

By Hayes T.J.   Ryffel B.  

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 1-4

Academic Press

Access to resources Recommend Favorite

Interleukin-12: Role of Interferon-gamma in IL-12 Adverse Effects

By Ryffel B.  

Clinical Immunology, Vol. 83, Iss. 1, 1997-04 ,pp. : 18-20

Academic Press

Access to resources Recommend Favorite